Repligen
RGEN
#1943
Rank
A$14.94 B
Marketcap
A$235.42
Share price
-2.02%
Change (1 day)
2.79%
Change (1 year)
Categories

Number of shares outstanding for Repligen (RGEN)

Number of shares outstanding as of October 2026 : 56,418,000

According to Repligen 's latest financial reports and stock price the company's current number of shares outstanding is 56,418,000. At the end of 2026 the company had 56,418,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Repligen from 1996 to 2026

Shares Outstanding at the end of each year

Year Shares Outstanding Change
202656.41 M0.19%
202556.31 M0.45%
202456.05 M0.43%
202355.81 M0.49%
202255.54 M0.43%
202155.3 M4.07%
202053.14 M2.07%
201952.06 M18.65%
201843.88 M0.72%
201743.56 M28.77%
201633.83 M2.69%
201532.94 M0.61%
201432.74 M2.6%
201331.91 M2.52%
201231.13 M1.09%
201130.79 M0.03%
201030.78 M0.09%
200930.75 M-0.17%
200830.8 M-0.47%
200730.95 M1.9%
200630.37 M0.9%
200530.1 M0.13%
200430.06 M0.62%
200329.87 M9.38%
200227.31 M2.53%
200126.64 M0.25%
200026.57 M19.75%
199922.19 M47.96%
199815 M12.5%
199713.33 M-33.33%
199620 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Pfizer
PFE
5,699,000,000 10,001.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
371,000,000 557.59%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
1,040,000,000 1,743.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2,042,000,000 3,519.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
389,616,000 590.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
164,574,000 191.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
101,000,000 79.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
156,090,000 176.67%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
193,423,000 242.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
48,021,000-14.88%๐Ÿ‡บ๐Ÿ‡ธ USA